Troubling Coverage Losses as Pandemic Scourges Forward
According to an analysis conducted by the healthcare advocacy organization Families USA, an estimated 5.5 million Americans who lost their...
Read MoreResearchers Screen First Participant in Drug Study to Prevent Early Alzheimer’s
Researchers at the University of Kentucky’s Sanders-Brown Center on Aging (SBCoA) have recently screened the first participant of the AHEAD...
Read MoreHidden in Plain Sight: an Alzheimer’s Reversal Agent
Alzheimer’s Disease has heretofore never had a cure. We use drugs such as donepezil to slow its progress, but we...
Read MoreFuture: Reducing Rate of Mosquito-Borne Diseases through Genetic Engineering
West Nile Virus, Malaria, Dengue Fever; some of the potentially fatal illnesses humans can receive from mosquitos. For years, efforts...
Read MoreModerna’s COVID-19 Vaccine Spurs Immune Response in Trial
Developers claim that a trial vaccine aimed at fighting COVID-19 has prompted an immune response in healthy adults. The vaccine...
Read MoreBiogen Seeks FDA Approval for First Drug Aimed at Slowing Alzheimer’s Disease
Biogen announced on July 8, 2020 that the company is seeking U.S. approval for the drug aducanumab. If granted approval...
Read MoreA Potential Repurposing of Existing Drugs to Combat Covid-19
In June of 2020, researchers from University of Arizona, University of South Florida Morsani College of Medicine, and Utah State...
Read MoreCOVID-19: Melatonin as a potential adjuvant treatment
There are researches showing that melatonin has positive effects in alleviating acute respiratory stress induced by virus, bacteria, radiation, etc....
Read MorePost-Intensive Care Syndrome in Geriatric Patients Recovering from COVID-19
Intensive care units see on average 19 million patients admitted each year, a statistic recorded prior to the outbreak of...
Read MoreStaring at a Deep Red Light Can Significantly Improve Declining Eyesight
A new study finds that staring at a deep red light for three minutes a day can significantly improve declining...
Read More